114 related articles for article (PubMed ID: 38453615)
1. Healthcare Resource Utilization and Cost-of-Illness in Systemic Light Chain (AL) Amyloidosis in Europe: Results From the Real-World, Retrospective EMN23 Study.
Jaccard A; Bridoux F; Roeloffzen W; Minnema MC; Bergantim R; Hájek R; João C; Cibeira MT; Palladini G; Schönland S; Merlini G; Milani P; Dimopoulos MA; Ravichandran S; Hegenbart U; Agis H; Gros B; Asra A; Magarotto V; Cheliotis G; Psarros G; Sonneveld P; Wechalekar A; Kastritis E
Clin Lymphoma Myeloma Leuk; 2024 May; 24(5):e205-e216. PubMed ID: 38453615
[TBL] [Abstract][Full Text] [Related]
2. Healthcare resource utilization and costs in amyloid light-chain amyloidosis: a real-world study using US claims data.
Quock TP; Yan T; Chang E; Guthrie S; Broder MS
J Comp Eff Res; 2018 Jun; 7(6):549-559. PubMed ID: 29390860
[TBL] [Abstract][Full Text] [Related]
3. Annual health care resource utilization and cost among type 2 diabetes patients with newly recognized chronic kidney disease within a large U.S. administrative claims database.
Folkerts K; Petruski-Ivleva N; Kelly A; Fried L; Blankenburg M; Gay A; Kovesdy CP
J Manag Care Spec Pharm; 2020 Dec; 26(12):1506-1516. PubMed ID: 33251992
[No Abstract] [Full Text] [Related]
4. Real-world treatment patterns, costs, and outcomes in patients with AL amyloidosis: analysis of the Optum EHR and commercial claims databases.
Dispenzieri A; Zonder J; Hoffman J; Wong SW; Liedtke M; Abonour R; D'Souza A; Lee C; Cote S; Potluri R; Ammann E; Tran N; Lam A; Nair S
Amyloid; 2023 Jun; 30(2):161-168. PubMed ID: 36282014
[TBL] [Abstract][Full Text] [Related]
5. A retrospective chart review study to quantify the monthly medical resource use and costs of treating patients with treatment resistant depression in the United Kingdom.
Denee T; Ming T; Waller J; Bailey T; Rajkovic-Hooley O; Middleton-Dalby C; Le HH; Zhang Q; McCrone P; Taylor D
Curr Med Res Opin; 2021 Feb; 37(2):311-319. PubMed ID: 33253055
[TBL] [Abstract][Full Text] [Related]
6. Attributable Healthcare Resource Utilization and Costs for Patients With Primary and Recurrent Clostridium difficile Infection in the United States.
Zhang D; Prabhu VS; Marcella SW
Clin Infect Dis; 2018 Apr; 66(9):1326-1332. PubMed ID: 29360950
[TBL] [Abstract][Full Text] [Related]
7. Treatment patterns and health care resource utilization among patients with relapsed/refractory systemic light chain amyloidosis.
Hari P; Lin HM; Asche CV; Ren J; Yong C; Luptakova K; Faller DV; Sanchorawala V
Amyloid; 2018 Mar; 25(1):1-7. PubMed ID: 29303358
[TBL] [Abstract][Full Text] [Related]
8. Health Care Resource Utilization and Exacerbation Rates in Patients with COPD Stratified by Disease Severity in a Commercially Insured Population.
Wallace AE; Kaila S; Bayer V; Shaikh A; Shinde MU; Willey VJ; Napier MB; Singer JR
J Manag Care Spec Pharm; 2019 Feb; 25(2):205-217. PubMed ID: 30698096
[TBL] [Abstract][Full Text] [Related]
9. The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018.
Palladini G; Schönland S; Merlini G; Milani P; Jaccard A; Bridoux F; Dimopoulos MA; Ravichandran S; Hegenbart U; Roeloffzen W; Cibeira MT; Agis H; Minnema MC; Bergantim R; Hájek R; João C; Leonidakis A; Cheliotis G; Sonneveld P; Kastritis E; Wechalekar A
Blood Cancer J; 2023 Jan; 13(1):19. PubMed ID: 36697388
[TBL] [Abstract][Full Text] [Related]
10. Patients with Idiopathic Membranous Nephropathy: A Real-World Clinical and Economic Analysis of U.S. Claims Data.
Nazareth TA; Kariburyo F; Kirkemo A; Xie L; Pavlova-Wolf A; Bartels-Peculis L; Vaidya N; Sim JJ
J Manag Care Spec Pharm; 2019 Sep; 25(9):1011-1020. PubMed ID: 31283419
[TBL] [Abstract][Full Text] [Related]
11. Real-World, Multinational, Retrospective Observational Survey of the ADAS-Cog and Associations with Healthcare Resource Utilization in Patients with Alzheimer's Disease.
Ritchie CW; Khandker RK; Pike J; Black CM; Jones E; Ambegaonkar BM
J Alzheimers Dis; 2018; 64(3):899-910. PubMed ID: 29966202
[TBL] [Abstract][Full Text] [Related]
12. Healthcare resource utilization and cost among patients with type 1 diabetes in the United States.
Simeone JC; Shah S; Ganz ML; Sullivan S; Koralova A; LeGrand J; Bushman J
J Manag Care Spec Pharm; 2020 Nov; 26(11):1399-1410. PubMed ID: 33119443
[No Abstract] [Full Text] [Related]
13. Multi-National, Cross-Sectional Survey of Healthcare Resource Utilization in Patients with All Stages of Cognitive Impairment, Analyzed by Disease Severity, Country, and Geographical Region.
Khandker RK; Ritchie CW; Black CM; Wood R; Jones E; Hu X; Ambegaonkar BM
J Alzheimers Dis; 2020; 75(4):1141-1152. PubMed ID: 32390613
[TBL] [Abstract][Full Text] [Related]
14. The burden of adult asthma in Finland: impact of disease severity and eosinophil count on health care resource utilization.
Viinanen A; Lassenius MI; Toppila I; Karlsson A; Veijalainen L; Idänpään-Heikkilä JJ; Laitinen T
J Asthma; 2020 Oct; 57(10):1092-1102. PubMed ID: 31267775
[No Abstract] [Full Text] [Related]
15. Economic burden of bilateral neovascular age-related macular degeneration: multi-country observational study.
Cruess AF; Zlateva G; Xu X; Soubrane G; Pauleikhoff D; Lotery A; Mones J; Buggage R; Schaefer C; Knight T; Goss TF
Pharmacoeconomics; 2008; 26(1):57-73. PubMed ID: 18088159
[TBL] [Abstract][Full Text] [Related]
16. A Real-World Claims Analysis of Costs and Patterns of Care in Treated Patients with Glioblastoma Multiforme in the United States.
Norden AD; Korytowsky B; You M; Kim Le T; Dastani H; Bobiak S; Singh P
J Manag Care Spec Pharm; 2019 Apr; 25(4):428-436. PubMed ID: 30917077
[TBL] [Abstract][Full Text] [Related]
17. Economic burden of fatigue or morning stiffness among patients with rheumatoid arthritis: a retrospective analysis from real-world data.
Strand V; Shah R; Atzinger C; Zhou J; Clewell J; Ganguli A; Tundia N
Curr Med Res Opin; 2020 Jan; 36(1):161-168. PubMed ID: 31433680
[No Abstract] [Full Text] [Related]
18. Health care resource utilization and burden of disease in a U.S. Medicare population with a principal diagnosis of osteoarthritis of the knee.
Chen F; Su W; Bedenbaugh AV; Oruc A
J Med Econ; 2020 Oct; 23(10):1151-1158. PubMed ID: 32715848
[TBL] [Abstract][Full Text] [Related]
19. Burden of pulmonary arterial hypertension in England: retrospective HES database analysis.
Exposto F; Hermans R; Nordgren Å; Taylor L; Sikander Rehman S; Ogley R; Davies E; Yesufu-Udechuku A; Beaudet A
Ther Adv Respir Dis; 2021; 15():1753466621995040. PubMed ID: 33620026
[TBL] [Abstract][Full Text] [Related]
20. Pain severity and healthcare resource utilization in patients with osteoarthritis in the United States.
Nalamachu S; Robinson RL; Viktrup L; Cappelleri JC; Bushmakin AG; Tive L; Mellor J; Hatchell N; Jackson J
Postgrad Med; 2021 Jan; 133(1):10-19. PubMed ID: 33131380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]